Trump Administration and MAHA Coalition Clash Over Glyphosate Protections

The alliance between President Donald Trump and the Make America Healthy Again (MAHA) movement is facing a critical test as the administration moves to protect the herbicide glyphosate from state-level litigation. The tension is manifesting in two primary arenas: the Supreme Court and the U.S. House of Representatives. The Supreme Court is set to hear arguments on whether federal law preempts state-level lawsuits alleging that glyphosate causes cancer. Simultaneously, the House is expected to consider a massive farm bill that includes provisions acting as a liability shield for pesticide manufacturers, prohibiting states from penalizing entities for failing to comply with labeling requirements that differ from EPA approvals. The MAHA coalition, which helped secure Trump's victory and includes HHS Secretary Robert F. Kennedy Jr., strongly opposes the chemical. This conflict follows a previous rupture in February when an executive order was signed to boost domestic glyphosate production, necessitating damage control from Kennedy. The administration's legal position, detailed in an amicus brief, argues that without federal preemption, manufacturers would face a chaotic patchwork of 50 different state labeling requirements, undermining the EPA's centralized health judgments. For Bayer, a favorable ruling would significantly mitigate the risk of 'failure to warn' claims that have cost the company billions. Politically, the rift comes at a sensitive time. With the 2026 midterm elections less than seven months away and slim Republican majorities in both chambers of Congress, maintaining the coalition between the administration and health activists is seen as critical for electoral stability.